Skip to main content
OpenTrials
Completed

NCT Number: NCT04660877

Blood and Muscle Response to Cheddar Cheese in Healthy Adults

The goal of this project is to use a cross over design in young healthy male and female adults:

1. To determine the amino acid blood response to the acute ingestion of cheddar cheese in comparison to that of milk. 2. To determine the muscle mTORC1 response to the acute ingestion of cheddar cheese in comparison to that of milk.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Utah

Salt Lake City, Utah, 84112, United States

About this study

Each subject will take part in two metabolic studies. Each metabolic study was designed to test the acute blood and muscle response to an ingested amount of either cheddar cheese or milk. Approximately, one month after the first experiment (Metabolic Study #1), the participant will complete the second experiment (Metabolic Study #2) which was exact in design and at the same time of day as the first study but the participant ingested the alternate food product. The morning of the metabolic studies, the participant will arrive at the clinical research center after a 10h fast. A catheter will be placed in the participants' arm for blood sampling. Next, the participant will undergo a fasted thigh skeletal muscle biopsy. Following the muscle biopsy, the participant will consume either cheddar cheese (65g) or milk (370 mL) each amounting to 20g of protein. Subsequent muscle biopsies will occur at 60 and 180min after product ingestion. Blood sampling will occur in the fasted state and periodically after ingestion of the products (up to 300min).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18-35y

Exclusion criteria

  • History of cardiovascular disease
  • History of endocrine or metabolic disease (e.g., hypo/hyperthyroidism, diabetes)
  • History of kidney disease or failure
  • History of liver disease
  • History of respiratory disease (acute upper respiratory infection, chronic lung disease)
  • History of stroke with motor disability
  • Use of anticoagulant therapy (e.g., Coumadin, heparin) including aspirin and fish oils within 7d of the first biopsy experiment
  • Elevated systolic blood pressure >150 or a diastolic blood pressure > 100
  • Smoking
  • Recent anabolic or corticosteroids use (within 12 weeks)
  • Pregnancy as determined by a pregnancy test
  • self report of lactose intolerance
  • Any other medical condition or event considered exclusionary by the PI and faculty physician

Treatment and study plan

Cheddar cheese

Dietary Supplement

20g of protein from cheddar cheese

Milk

Dietary Supplement

20g of protein from milk

Primary outcomes

  1. Response to cheese or milk ingestion

    Time frame: Area under the curve 0-300min after ingestion

    blood amino acids area under the curve in response to acute stimulation of cheese or milk consumption

Secondary outcomes

  1. Response to cheese or milk ingestion

    Time frame: Change between 60min after ingestion and fasted response

    muscle mTORC1 change in response to acute stimulation of cheese or milk

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Official study title

Anabolic Effects of Cheddar Cheese Consumption in Human Skeletal Muscle

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Dec 9, 2020
Registry last updated
Jun 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.